ConductScience.org, home

Paper25751641

Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Zhang X and 6 others. Hum Vaccin Immunother, 2015. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins. Papers, record 25751641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25751641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.
PubMed
Journal
Hum Vaccin Immunother
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.54
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang XXiao
2Xin LLu
3Li SShaowei
4Fang MMujin
5Zhang JJun
6Xia NNingshao
7Zhao QQinjian

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Capsid ProteinsMajor topic
EpitopesMajor topic
Papillomavirus VaccinesMajor topic
Vaccines, Virus-Like ParticleMajor topic
Viral Hepatitis VaccinesMajor topic
Drug Discovery
Humans
Technology, Pharmaceutical
Vaccines, Synthetic

Source PubMed

Download CSV of topics

References157

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18046412Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera.J Gen Virol1994https://conductscience.org/library/papers/8046412PubMed
223281113Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts.Protein Sci2013https://conductscience.org/library/papers/23281113PubMed
320598725Study of infectious virus production from HPV18/16 capsid chimeras.Virology2010https://conductscience.org/library/papers/20598725PubMed
410233949Characterization of a major neutralizing epitope on human papillomavirus type 16 L1.J Virol1999https://conductscience.org/library/papers/10233949PubMed
520139221Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.J Natl Cancer Inst2010https://conductscience.org/library/papers/20139221PubMed
619374929Influenza vaccines based on virus-like particles.Virus Res2009https://conductscience.org/library/papers/19374929PubMed
722356831Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.Virol J2012https://conductscience.org/library/papers/22356831PubMed
82997616Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata.Nature1985https://conductscience.org/library/papers/2997616PubMed
99680478Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution.J Mol Biol1998https://conductscience.org/library/papers/9680478PubMed
1010639310HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain.Virology2000https://conductscience.org/library/papers/10639310PubMed
1111738749Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.Vaccine2001https://conductscience.org/library/papers/11738749PubMed
1217403562Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.Vaccine2007https://conductscience.org/library/papers/17403562PubMed
132170694Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11.J Virol1990https://conductscience.org/library/papers/2170694PubMed
148392600Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein.J Virol1993https://conductscience.org/library/papers/8392600PubMed
1511878901Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.Virology2001https://conductscience.org/library/papers/11878901PubMed
1616310896Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.Vaccine2006https://conductscience.org/library/papers/16310896PubMed
1720420879Characterization of the lipid and protein organization in HBsAg viral particles by steady-state and time-resolved fluorescence spectroscopy.Biochimie2010https://conductscience.org/library/papers/20420879PubMed
1817329696Safety and efficacy of a recombinant hepatitis E vaccine.N Engl J Med2007https://conductscience.org/library/papers/17329696PubMed
1922144891Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.PLoS Pathog2011https://conductscience.org/library/papers/22144891PubMed
2015780738A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.Vaccine2005https://conductscience.org/library/papers/15780738PubMed

See all 157 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42112438Engineering strategies and decision frameworks for virus-like particle-based vaccines against infectious diseases.Front Microbiol2026https://conductscience.org/library/papers/42112438PubMed
42012184Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.J Virol2026https://conductscience.org/library/papers/42012184PubMed
41691583Immune Responses to Human Papillomavirus After Infection and Vaccination.Curr Top Microbiol Immunol2026https://conductscience.org/library/papers/41691583PubMed
40240438Discovery of novel HBV core protein inhibitors by high throughput virtual screening.Sci Rep2025https://conductscience.org/library/papers/40240438PubMed
39772006Protein Expression Platforms and the Challenges of Viral Antigen Production.Vaccines (Basel)2024https://conductscience.org/library/papers/39772006PubMed
37629147Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.Int J Mol Sci2023https://conductscience.org/library/papers/37629147PubMed
37441076Computational formulation of a multiepitope vaccine unveils an exceptional prophylactic candidate against Merkel cell polyomavirus.Front Immunol2023https://conductscience.org/library/papers/37441076PubMed
32880435Engineering a Virus-like Particle to Display Peptide Insertions Using an Apparent Fitness Landscape.Biomacromolecules2020https://conductscience.org/library/papers/32880435PubMed
32349216Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines.Viruses2020https://conductscience.org/library/papers/32349216PubMed
32131431Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus.Vaccines (Basel)2020https://conductscience.org/library/papers/32131431PubMed
31995442Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent.Hum Vaccin Immunother2020https://conductscience.org/library/papers/31995442PubMed
31963175Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation.Viruses2020https://conductscience.org/library/papers/31963175PubMed
31376116Recent trends and advances in microbe-based drug delivery systems.Daru2019https://conductscience.org/library/papers/31376116PubMed
30845175Efficient expression of enterovirus 71 based on virus-like particles vaccine.PLoS One2019https://conductscience.org/library/papers/30845175PubMed
30172637Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine.Vaccine2018https://conductscience.org/library/papers/30172637PubMed
29263864Escherichia coli-derived virus-like particles in vaccine development.NPJ Vaccines2017https://conductscience.org/library/papers/29263864PubMed
29137642Effects of mRNA secondary structure on the expression of HEV ORF2 proteins in Escherichia coli.Microb Cell Fact2017https://conductscience.org/library/papers/29137642PubMed
28902491Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing.ACS Nano2017https://conductscience.org/library/papers/28902491PubMed
28004837The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.Sci Rep2016https://conductscience.org/library/papers/28004837PubMed
27184971Hepatitis E virus: Current epidemiology and vaccine.Hum Vaccin Immunother2016https://conductscience.org/library/papers/27184971PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25751641

GET https://conductscience.org/api/papers/v1/25751641/references?page=2